NovoCure – the company known for its novel approach to treat solid tumors with electric fields — has filed for an IPO to raise up to $300 million. The Israeli medical device pioneer received FDA approval in 2011 for its TTFields product designed to treat Glioblastoma brain cancer. Chief underwriters...
Continue Reading >>
PA Doubles Pay-To-Slay Salary of Terrorist Behind Murder of Three Israeli Teens
After reports earlier this week that the Palestinian Authority (PA) stepped up its support for the sickening “pay-to-slay” policy by














